DAY ONE - Tuesday 29 June
09.30 Registration & coffee
10.00 Opening remarks from Chair
10.15 Evaluating the last 12 months of the Chinese API market and how this will impact future growth
• Examining the key factors behind the recent decline in the Chinese API sector
• Outlining how fears in quality have led to mass improvement and subsequently future growth
• Exploring the key factors behind rising prices in China: will this impact future growth?
• Highlighting those ‘hidden costs’ – increasing salaries, regulation and environmental
• Analysing a more and more established market: are there any possible gaps in technology and/or skills?
10.45 Examining India’s focus on APIs and those increasing opportunities
• Forecasting growth trends in the Indian API market
• Analysing the key factors behind why the Indian market has remained ‘recession-proof’
• Investigating the factors behind continued growth: increasing R&D, ANDAs and DMF
• Comparing the competitive advantages of the India sourcing market over China
• Exploring possible barriers to continued growth: how will increasing costs in salaries and raw materials affect future growth?
• Filling the gaps in technology through acquisitions: what affect does this have for future investment?
Shannon Bennett, Pharmaceutical Research Analyst, Healthcare & Science, Thomson Reuters
11.15 Questions and answers from the previous two presentations
11.30 Refreshments & networking
12.00 Risk management for API sourcing in emerging markets
• Standard approaches for risk management
• Evaluating the key risks of emerging suppliers
• Support by agents
• Mitigating the risks of second tier suppliers
• Investigating what safeguards can be implemented to safeguard against IP theft
Dr Volker Hartmann, Head of Corporate Purchasing, Production Material, Boehringer Ingelheim GmbH
12.45 Lunch
14.00 Interview: Gaining a greater understanding of your potential partners in China
This is your unique opportunity to discover what advice potential partners can give you. Navigate the challenges together and benefit from pooled and shared knowledge. Have your questions answered in our new interview format.
Dr Leo Jin, Associate, Pharmaventures (based in China)
14.45 Investigating solutions and highlighting best practice for entering a new emerging market
• Utilizing a global base: what is the best way to ‘make your mark’?
• Sourcing local knowledge – working in tandem and in partnerships
• Evaluating the role of local consultants
Kevin Bottomley, Senior Principal, PharmaVentures
15.20 Refreshments & networking
16.00 Build key partnerships across the API industry
17.00 Close of day one
DAY TWO - Wednesday 30 June
09.00 Opening remarks from chair
09.10 Assessing the impact of emerging Asian markets on the USA and Europe
• Exploring how an increase in the quality of Asian suppliers is leading to a decline in the USA
• Examining how an unstable future for American suppliers will affect the global market
• Slipping under the radar: as India and China steal the limelight, can Russia and Poland continue to push forwards?
Dr Keith Schlagbauer, Director of Healthcare Consulting, Frost & Sullivan
09.50 Questioning whether globalisation is cost-effective in the long-term
• Comparing other industries: how does pharma compare?
• Exploring the effect of increasing oil prices on production and transportation
• Investigating how despite increasing quality in emerging suppliers, an increase in associated costs of salaries, production and transportation could bring API supply full circle
Hugo Peeters, Secretary to the German Pharmacopoeia Commission, BFARM
10.30 Refreshments & networking
11.00 Selecting the right partner for you and your business – mitigating the risk for the first time
• Looking at where to begin: how to cost-effectively and efficiently identify a comprehensive list of potential partners
• Using historical investigations to examine previous compliance with GMP regulations
• Utilizing available databases, supplier identification grids and matrixes to match the needs of buyer of supplier
• Taking the next step: auditing facilities, systems and other partners
Burghard Freiberg, Senior Vice President Performance and Life Science Chemicals, Merck
11.40 Building durable partnerships to secure long-term business relationships with Asia
• Understanding your partners’ needs, wants and culture
• Optimising your SRM strategy to maintain lasting relationships and goodwill
• Creating transparency across all parties, and communicating timelines and deadlines
• Developing an on going quality control programme to continually monitor and increase compliance
12.20 Lunch
13.20 The global sourcing challenge
• Assessing the benefits to having regulatory agreements across all relationships and parties
• Highlighting possible pitfalls of globalisation and the inability to easily control compliance
• Processing validation activities through the necessary documentation and guides
• Setting realistic goals and managing your expectations
James Booker, Sourcing Manager, AstraZeneca
14.00 Interview
Gaining a greater understanding of your potential partners: India
This is your unique opportunity to discover what advice potential partners can give you. Navigate the challenges together and benefit from pooled and shared knowledge. Have your questions answered in our new interview format.
Seshnath Chauhan, Associate Director - API Sourcing, Dr Reddy’s Laboratories Limited, India
14.40 Refreshments & networking
15.10 SRM Masterclass: Streamlining the number of suppliers for cost-effective management
• Optimising your SRM: what is the ideal number of suppliers for your organisation?
• Measuring good experience and good business – choosing the best suppliers
• Making the legal considerations: top tips for contract management
Gordon Ewert, Shire
15.50 Closing remarks from chair
